학술논문
Overall survival (OS) by response to first-line (1L) induction treatment with atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem in patients (pts) with metastatic urothelial carcinoma (mUC): Updated data from the IMvigor130 OS...
Document Type
Article
Author
Grande, Enrique; Bamias, Aristotelis; Galsky, Matt D.; Kikuchi, Eiji; Davis, Ian D.; Arranz, José A.; Rezazadeh, Arash; Garcia del Muro, Xavier; Park, Se Hoon; De Giorgi, Ugo; Alekseev, Boris; Mencinger, Marina; Izumi, Kouji; Puente, Javier; Li, Jian-Ri; Lee, Chooi; Bernhard, Sandrine; Nicholas, Alan; Telliez, Julie; De Santis, Maria
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p4503-4503, 1p
Subject
Language
ISSN
0732183X